AHA 2005

Eicosapentaenoic Acid: Prevention of Coronary Artery Disease

A 20 000-person study of eicosapentaenoic acid supplements gave solid scientific support for EPA use to prevent cardiovascular events among patients with established coronary artery disease. Mitsuhiro Yokoyama of Kobe University told us more about it.

Click here for all the interviews from AHA 2005

Similar Interviews

  • Audio Journal of Medicine: Gene Study Identifies Heart Disease Risk">Audio Journal of Medicine: Gene Study Identifies Heart Disease Risk
  • Nilesh Samani REFERENCE: N Engl J Med 2007; 357: 443-53 NILESH SAMANI, University of Leicester UK Previously

  • Raw Deal for European Women with Coronary Artery Disease
  • Caroline Daly The Euroheart survey has found significant differences in both diagnosis and treatment of heart disease in women as compared

  • Pexelizumab Reduces Mortality in High Risk Coronary Artery By-Pass Patients
  • Peter Smith, Duke University Medical Center, Durham, NC Late Breaking Clinical Trials, ACC Atlanta 2006, Sunday 12th March 2006 The drug pexelizumab,

    Post a comment

    Subscribe to Audio Medica Podcast